JP2020521761A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521761A5 JP2020521761A5 JP2019565281A JP2019565281A JP2020521761A5 JP 2020521761 A5 JP2020521761 A5 JP 2020521761A5 JP 2019565281 A JP2019565281 A JP 2019565281A JP 2019565281 A JP2019565281 A JP 2019565281A JP 2020521761 A5 JP2020521761 A5 JP 2020521761A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- set forth
- domain set
- human subject
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024022711A JP2024069230A (ja) | 2017-05-26 | 2024-02-19 | 慢性回腸嚢炎の治療のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511832P | 2017-05-26 | 2017-05-26 | |
| US62/511,832 | 2017-05-26 | ||
| PCT/IB2018/053760 WO2018215995A1 (en) | 2017-05-26 | 2018-05-26 | Methods for the treatment of chronic pouchitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024022711A Division JP2024069230A (ja) | 2017-05-26 | 2024-02-19 | 慢性回腸嚢炎の治療のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521761A JP2020521761A (ja) | 2020-07-27 |
| JP2020521761A5 true JP2020521761A5 (enExample) | 2021-07-26 |
| JP7497159B2 JP7497159B2 (ja) | 2024-06-10 |
Family
ID=64395342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565281A Active JP7497159B2 (ja) | 2017-05-26 | 2018-05-26 | 慢性回腸嚢炎の治療のための方法 |
| JP2024022711A Pending JP2024069230A (ja) | 2017-05-26 | 2024-02-19 | 慢性回腸嚢炎の治療のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024022711A Pending JP2024069230A (ja) | 2017-05-26 | 2024-02-19 | 慢性回腸嚢炎の治療のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20200087401A1 (enExample) |
| EP (1) | EP3630184A4 (enExample) |
| JP (2) | JP7497159B2 (enExample) |
| KR (1) | KR20200011457A (enExample) |
| AU (1) | AU2018274749B2 (enExample) |
| BR (1) | BR112019024875A2 (enExample) |
| CA (1) | CA3065000A1 (enExample) |
| IL (1) | IL270819A (enExample) |
| MX (1) | MX2019014090A (enExample) |
| WO (1) | WO2018215995A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3581585A1 (en) | 2014-11-26 | 2019-12-18 | Millennium Pharmaceuticals, Inc. | Vedolizumab for the treatment of fistulizing crohn's disease |
| WO2023163883A1 (en) * | 2022-02-22 | 2023-08-31 | First Wave BioPharma, Inc. | Compositions and methods for treating pouchitis |
| WO2024249568A1 (en) | 2023-05-30 | 2024-12-05 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6551593B1 (en) * | 1995-02-10 | 2003-04-22 | Millennium Pharmaceuticals, Inc. | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
| UA116189C2 (uk) * | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| US20170360926A1 (en) * | 2014-12-24 | 2017-12-21 | Millennium Pharmaceuticals, Inc. | PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY |
-
2018
- 2018-05-26 KR KR1020197037702A patent/KR20200011457A/ko not_active Ceased
- 2018-05-26 US US16/617,254 patent/US20200087401A1/en not_active Abandoned
- 2018-05-26 WO PCT/IB2018/053760 patent/WO2018215995A1/en not_active Ceased
- 2018-05-26 JP JP2019565281A patent/JP7497159B2/ja active Active
- 2018-05-26 AU AU2018274749A patent/AU2018274749B2/en active Active
- 2018-05-26 BR BR112019024875-7A patent/BR112019024875A2/pt unknown
- 2018-05-26 CA CA3065000A patent/CA3065000A1/en active Pending
- 2018-05-26 EP EP18806578.3A patent/EP3630184A4/en active Pending
- 2018-05-26 MX MX2019014090A patent/MX2019014090A/es unknown
-
2019
- 2019-11-21 IL IL270819A patent/IL270819A/en unknown
-
2022
- 2022-03-18 US US17/655,541 patent/US20230043949A1/en active Pending
-
2024
- 2024-02-19 JP JP2024022711A patent/JP2024069230A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| PH12020551491A1 (en) | USE OF ANTI-HUMAN SIRPA Vl ANTIBODIES AND METHOD FOR PRODUCING ANTI-SIRPA Vl ANTIBODIES | |
| JP2014534239A5 (enExample) | ||
| EA202091590A1 (ru) | Антитела против pd-l1 и варианты их применения | |
| RU2017108173A (ru) | Комбинированная терапия на основе антител, активирующих человеческий cd40, и антител к человеческому pd-l1 | |
| JP2015514110A5 (enExample) | ||
| RU2011129204A (ru) | Антитела против ангиопоэтина-2 человека | |
| JP2017507652A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2018508573A5 (enExample) | ||
| JP2019513751A5 (enExample) | ||
| JP2019523295A5 (enExample) | ||
| RU2012156938A (ru) | Антитела против gdf8 человека | |
| JP2018507220A5 (enExample) | ||
| JP2019505527A5 (enExample) | ||
| JP2012525128A5 (enExample) | ||
| JP2017506626A5 (enExample) | ||
| JP2018506277A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| RU2021129189A (ru) | Антитела против фактора свертывания xi | |
| JP2016507470A5 (enExample) | ||
| CY1113489T1 (el) | Αντισωμα το οποιο δεσμευει αλφα4βητα7 ιντεγκρινη και η χρηση αυτου εις τη θεραπευτικη αγωγη της φλεγμονωδους νοσου του εντερου | |
| JP2018529661A5 (enExample) | ||
| JP2021504412A5 (enExample) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение |